Drugs / α-Mangostin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06039774 | Dec 2023 → Jun 2024 | aphthous stomatitis | Padjadjaran University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | α-Mangostin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06039774 ↗ |
| Known as | α-M | “α-Mangostin (α-M) from mangosteen rind (Garcinia mangostana L) has been shown its effect to reduce oral mucosal sores on RAS in preclinical studies in rats.” NCT06039774 ↗ |
| Modality | Small molecule | “α-mangostin is a xanthone isolated from the rind of the mangosteen fruit.” PMID 38434698 ↗ Feb 2024 |
| Route | Topical | “Patients will apply α-Mangostin Hydrogel Film With Chitosan Alginate Base once a day for 7 days” NCT06039774 ↗ |